Gabapentin Capsule
Product Images NDC 63629-8487

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-8487). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Line graph showing mean pain scores over an 8-week period comparing placebo and Gabapentin at 3600 mg/day. The graph includes annotations for a 4-week dose titration period followed by a 4-week fixed dose period, with pain scores on the vertical axis and weeks on the horizontal axis.*

FDA Label Image

Figure 2 (Image 02)

Line graph showing mean pain scores over 7 weeks comparing placebo with Gabapentin 1800 mg/day and 2400 mg/day. X-axis represents weeks (baseline to week 7), Y-axis represents mean pain score (0 to 10). The graph indicates treatment periods: a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled "Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies" comparing placebo (PBO) and gabapentin (GBP) doses in two studies. The y-axis shows percentage from 0% to 100%. Study 1 shows 12% responders for PBO and 29% for GBP 3600 mg, with statistical significance indicated. Study 2 shows 14% responders for PBO, 32% for GBP 1800 mg, and 34% for GBP 2400 mg, also with statistical significance.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

An illustration depicting a formula for estimating creatinine clearance (CLCr). The formula includes variables for age in years, weight in kilograms, serum creatinine in mg/dL, and a factor adjusting for female patients. This image explains how to calculate CLCr mathematically.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin, showing the molecular arrangement including a cyclohexane ring attached to an amino group (CH2NH2) and a carboxyl group (CH2CO2H).*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart showing the percentage difference on the vertical axis against daily dose (mg) on the horizontal axis. Data points represent three studies labeled as Study a, Study b, and Study c, distinguished by different colored squares. The chart compares difference percentages at various daily doses of 600, 900, 1200, and 1800 mg.*

FDA Label Image

Label (Lbl636298487)

Gabapentin Capsule, USP 300 mg label from Bryant Ranch Prepack. The label features a barcode, NDC 63629-8487-1, and indicates the product contains 100 capsules. It includes storage instructions and manufacturer details for Sciegen Pharmaceuticals, Inc., and relabeler information for Bryant Ranch Prepack, Inc. The label is primarily white with black and red text and the BRP Pharmaceuticals logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.